Related Experiment Video
Updated: Jan 24, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Targeted Therapies for Brain Metastases
Ajay Niranjan1, L Dade Lunsford2, Manmeet S Ahluwalia3
1Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA, niraax@UPMC.EDU.
Abstract:
The most common primary cancers that metastasize to the brain are lung cancer, breast cancer, and melanoma. The established management approaches for brain metastasis include stereotactic radiosurgery, fractionated radiation therapy, and surgical resection. In the past the role of medical therapies in brain metastases was limited. In the last decade, our understanding of molecular drivers of brain metastases and CNS penetration of drugs across the blood-brain barrier has improved. The molecular targeted tyrosine kinase inhibitors have shown effectiveness in brain metastases with activating mutations from non-small cell lung cancer, breast cancer, and melanoma. More recently, immunotherapies have also shown efficacy in the management of these patients. These agents can be effective for both intracranial as well as extracranial disease and are being actively employed in this patient population.
Insights
New medical therapies, including targeted tyrosine kinase inhibitors and immunotherapies, are improving outcomes for brain metastases from lung, breast, and melanoma cancers. These treatments offer new hope for patients with both brain and widespread disease.
Area of Science:
- Neuro-oncology
- Cancer Metastasis
- Pharmacology
Background:
- Brain metastases are common in lung cancer, breast cancer, and melanoma.
- Traditional treatments include surgery and radiation therapy.
- The role of medical therapies for brain metastases was historically limited.
Purpose of the Study:
- To review advancements in medical therapies for brain metastases.
- To highlight the efficacy of molecularly targeted agents and immunotherapies.
- To discuss the improved understanding of drug penetration across the blood-brain barrier.
Main Methods:
- Review of recent literature on brain metastases management.
- Analysis of clinical data for targeted therapies and immunotherapies.
- Discussion of molecular drivers and blood-brain barrier penetration.
Main Results:
- Molecular targeted tyrosine kinase inhibitors show effectiveness in brain metastases with specific mutations.
- Immunotherapies have demonstrated efficacy in managing brain metastases.
- These agents are effective for both intracranial and extracranial disease.
Conclusions:
- Medical therapies have significantly advanced the treatment of brain metastases.
- Targeted therapies and immunotherapies represent a paradigm shift in managing these complex cases.
- Further research is ongoing to optimize treatment strategies.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Group Therapy
Psychodynamic Therapy
Humanistic Therapy
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

